Published in J Investig Med on January 01, 2007
RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration. J Clin Invest (2012) 1.92
AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J Clin Invest (2013) 1.84
Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner. Am J Pathol (2008) 1.11
Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy. Am J Pathol (2011) 0.88
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest (2004) 1.73
SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest (2008) 1.48
HDL remodeling during the acute phase response. Arterioscler Thromb Vasc Biol (2008) 1.40
Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner. Am J Pathol (2008) 1.11
A murine model of obesity with accelerated atherosclerosis. Obesity (Silver Spring) (2009) 1.10
Serum amyloid A in atherosclerosis. Curr Opin Lipidol (2011) 1.09
Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development. J Lipid Res (2007) 1.08
Clinical efficacy and patient satisfaction with U-500 insulin use. Diabetes Res Clin Pract (2010) 1.04
Thiol oxidative stress induced by metabolic disorders amplifies macrophage chemotactic responses and accelerates atherogenesis and kidney injury in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol (2009) 1.02
Transforming growth factor-β regulation of proteoglycan synthesis in vascular smooth muscle: contribution to lipid binding and accelerated atherosclerosis in diabetes. J Diabetes (2010) 0.99
Köbberling type of familial partial lipodystrophy: an underrecognized syndrome. Diabetes Care (2003) 0.95
Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2013) 0.91
Extreme insulin resistance: indications and approaches to the use of U-500 insulin in type 2 diabetes mellitus. Curr Diab Rep (2011) 0.90
Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy. Am J Pathol (2011) 0.88
Differential effects of rosiglitazone and insulin glargine on inflammatory markers, glycemic control, and lipids in type 2 diabetes. Diabetes Res Clin Pract (2007) 0.87
Decreased body fat, elevated plasma transforming growth factor-β levels, and impaired BMP4-like signaling in biglycan-deficient mice. Connect Tissue Res (2012) 0.85
Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo. J Cell Mol Med (2009) 0.84
Serum amyloid A is found on ApoB-containing lipoproteins in obese humans with diabetes. Obesity (Silver Spring) (2013) 0.82
Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical management. Postgrad Med (2010) 0.82
Prevention of TGFβ induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr-/- mice. J Lipid Res (2013) 0.82
Salinity acclimation affects the somatotropic axis in rainbow trout. Am J Physiol Regul Integr Comp Physiol (2004) 0.82
Endogenous androgen deficiency enhances diet-induced hypercholesterolemia and atherosclerosis in low-density lipoprotein receptor-deficient mice. Gend Med (2012) 0.81
Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDL. J Lipid Res (2003) 0.81
Glucosamine inhibits the synthesis of glycosaminoglycan chains on vascular smooth muscle cell proteoglycans by depletion of ATP. Arch Physiol Biochem (2008) 0.81
Durability of glycemic control using U-500 insulin. Diabetes Res Clin Pract (2011) 0.80
Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice. J Lipid Res (2010) 0.79
Management of new-onset diabetes mellitus after transplantation. Postgrad Med (2008) 0.76
U-500: a convenient insulin for a convenience food nation. Endocr Pract (2013) 0.75
METABOLIC EFFECTS OF HORMONE THERAPY IN TRANSGENDER PATIENTS. Endocr Pract (2015) 0.75
Role of dyslipidemia in patients with chronic kidney disease. Postgrad Med (2013) 0.75